September 18, 2019 — Early use of an implantable cardioverter-defibrillator (ICD) after primary coronary intervention ...
September 18, 2019 — Discharge of patients with suspected acute coronary syndromes under a 0- and 1-hour high ...
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
September 17, 2019 — The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management ...
September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...
September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the ...
A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...
September 11, 2019 — Percutaneous reduction of secondary mitral regurgitation in patients with heart failure does not ...
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...
September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...
September 10,2019 — The combination of ticagrelor and aspirin reduces ischemic events compared with aspirin alone in ...
September 10, 2019 — An international randomized trial has shown that complete revascularization reduces major ...
September 9, 2019 — Prasugrel is superior to ticagrelor for reducing ischemic events in patients with acute coronary ...
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...
September 18, 2019